PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MannKind Corporation (MNKD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS56400P7069
CUSIP56400P706
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$1.80B
EPS (TTM)$0.05
PE Ratio131.20
PEG Ratio-0.23
Total Revenue (TTM)$248.37M
Gross Profit (TTM)$177.08M
EBITDA (TTM)$53.70M
Year Range$3.17 - $6.68
Target Price$7.80
Short %15.17%
Short Ratio14.51

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in MannKind Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%AprilMayJuneJulyAugustSeptember
36.06%
7.85%
MNKD (MannKind Corporation)
Benchmark (^GSPC)

Returns By Period

MannKind Corporation had a return of 80.22% year-to-date (YTD) and 51.15% in the last 12 months. Over the past 10 years, MannKind Corporation had an annualized return of -14.42%, while the S&P 500 had an annualized return of 10.88%, indicating that MannKind Corporation did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date80.22%18.13%
1 month27.63%1.45%
6 months40.47%8.81%
1 year51.15%26.52%
5 years (annualized)37.95%13.43%
10 years (annualized)-14.42%10.88%

Monthly Returns

The table below presents the monthly returns of MNKD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-8.24%23.05%10.22%-9.27%13.63%11.78%10.34%8.68%80.22%
20233.80%-3.47%-22.35%-6.10%20.52%-12.28%12.29%0.88%-10.41%3.87%-15.62%0.55%-30.93%
2022-14.65%-29.76%40.46%-14.95%33.55%-8.85%-9.45%5.80%-15.34%9.39%38.46%12.61%20.59%
202112.46%62.22%-31.35%16.58%-3.28%23.30%-24.77%17.07%-9.37%8.28%-1.70%-5.62%39.62%
202013.95%-13.61%-18.90%26.21%16.15%15.89%-10.86%11.54%8.05%6.91%48.26%5.03%142.64%
201918.87%42.06%10.06%-21.83%-24.68%-0.86%-2.61%-1.79%13.64%4.40%-5.75%4.88%21.70%
201817.24%7.72%-22.18%-25.44%17.65%-5.00%-18.95%-28.57%66.36%-0.00%-2.73%-40.45%-54.31%
201710.57%-24.72%-44.15%-40.97%73.99%-7.24%-7.80%59.23%4.83%51.61%-5.47%-25.40%-27.12%
2016-31.22%3.28%56.31%-16.15%-29.63%22.11%-14.66%-19.09%-22.60%-32.71%12.78%35.32%-56.09%
201521.76%2.68%-20.25%-17.50%20.75%9.85%-24.60%-11.66%-15.30%3.12%-39.58%-27.50%-72.20%
20144.23%14.21%-35.06%62.94%35.88%23.15%-23.72%-11.84%-19.81%1.69%2.33%-15.20%0.29%
20134.76%6.20%31.91%16.52%68.61%-2.33%18.52%-24.90%-1.55%-13.95%1.73%4.21%125.11%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of MNKD is 72, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of MNKD is 7272
MNKD (MannKind Corporation)
The Sharpe Ratio Rank of MNKD is 7575Sharpe Ratio Rank
The Sortino Ratio Rank of MNKD is 7272Sortino Ratio Rank
The Omega Ratio Rank of MNKD is 6969Omega Ratio Rank
The Calmar Ratio Rank of MNKD is 6868Calmar Ratio Rank
The Martin Ratio Rank of MNKD is 7474Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for MannKind Corporation (MNKD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


MNKD
Sharpe ratio
The chart of Sharpe ratio for MNKD, currently valued at 0.98, compared to the broader market-4.00-2.000.002.000.98
Sortino ratio
The chart of Sortino ratio for MNKD, currently valued at 1.57, compared to the broader market-6.00-4.00-2.000.002.004.001.57
Omega ratio
The chart of Omega ratio for MNKD, currently valued at 1.19, compared to the broader market0.501.001.501.19
Calmar ratio
The chart of Calmar ratio for MNKD, currently valued at 0.52, compared to the broader market0.001.002.003.004.005.000.52
Martin ratio
The chart of Martin ratio for MNKD, currently valued at 3.76, compared to the broader market-10.000.0010.0020.003.76
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.10, compared to the broader market-4.00-2.000.002.002.10
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.82, compared to the broader market-6.00-4.00-2.000.002.004.002.82
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.501.001.501.38
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.88, compared to the broader market0.001.002.003.004.005.001.88
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 11.08, compared to the broader market-10.000.0010.0020.0011.08

Sharpe Ratio

The current MannKind Corporation Sharpe ratio is 0.98. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of MannKind Corporation with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00AprilMayJuneJulyAugustSeptember
0.98
2.10
MNKD (MannKind Corporation)
Benchmark (^GSPC)

Dividends

Dividend History


MannKind Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AprilMayJuneJulyAugustSeptember
-94.47%
-0.58%
MNKD (MannKind Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the MannKind Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the MannKind Corporation was 99.41%, occurring on May 3, 2017. The portfolio has not yet recovered.

The current MannKind Corporation drawdown is 94.47%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.41%Sep 24, 20043173May 3, 2017
-22.4%Aug 2, 200410Aug 13, 200413Sep 1, 200423
-1.22%Sep 14, 20041Sep 14, 20042Sep 16, 20043
-0.5%Jul 29, 20041Jul 29, 20041Jul 30, 20042

Volatility

Volatility Chart

The current MannKind Corporation volatility is 13.86%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%AprilMayJuneJulyAugustSeptember
13.86%
4.08%
MNKD (MannKind Corporation)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of MannKind Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of MannKind Corporation compared to its peers in the Biotechnology industry.


PE Ratio
500.01,000.01,500.02,000.0131.2
The chart displays the price to earnings (P/E) ratio for MNKD in comparison to other companies of the Biotechnology industry. Currently, MNKD has a PE value of 131.2. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.
PEG Ratio
-1,000.0-800.0-600.0-400.0-200.00.0-0.2
The chart displays the price to earnings to growth (PEG) ratio for MNKD in comparison to other companies of the Biotechnology industry. Currently, MNKD has a PEG value of -0.2. This PEG value is considered to be low compared to the rest of the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for MannKind Corporation.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items